> Temcell in Japan - an important symbolic moment for the company, but it was NEVER going to make anyone rich in itself and to be fair, off-the-shelf cell therapies will take their own time to win over medical community interest and frankly, the initial market is not huge.
> Temcell is however [slowly] winning medical community interest, as evidenced by the product being trialed now for EB. So the longer-term road, for this one MSB product does look promising.
> re partnerships. Remember "no news is [generally] good news" and a good partnership takes time and I'd personally not now expect any particular news on this front until into 2017. I have no-doubt Bill Burns and his team will deliver when the time and deal is right, we want the best outcome for MSB, so doing it right is what matters - not doing it fast!
Q1 Update ?, page-5
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.015(1.29%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $4.551M | 3.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 98246 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 19079 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |